Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to Eviplera in HIV Patients with CNS Toxicity
NCT01701882Phase 3Completed
- Sponsor
- St Stephen's AIDS Trust
- Start
- Sep 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rilpivirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by St Stephen's AIDS Trust. Started Sep 2012; status: completed.
02
Drugs
rilpivirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01701882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01701882.